AUA 2013 - Poster: Optimal timing for treatment of metastatic castration-resistant prostate cancer (mCRPC): Sequencing and identifying parameters of early progression with sipuleucel-T

SAN DIEGO, CA USA (UroToday.com) - Presented by E. David Crawford, MD,1 Adam S. Kibel, MD,2 and Neal D.Shore, MD, FAC 3 at the American Urological Association (AUA) Annual Meeting - May 4 - 8, 2013 - San Diego Convention Center - San Diego, California USA

Optimal Timing for Treatment of mCRPC- Sequencing and Identifying Parameters of Early Progression with sip-T thumb

1University of Colorado Anschutz Medical Campus, Aurora, CO; 2Brigham and Women’s Hospital, Boston, MA; 3Atlantic Urology Clinics, Myrtle Beach, SC

 

aua

View Full AUA 2013 Coverage

 

 

 

 

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe